[go: up one dir, main page]

WO2012008747A3 - Skin diagnosis method and kit - Google Patents

Skin diagnosis method and kit Download PDF

Info

Publication number
WO2012008747A3
WO2012008747A3 PCT/KR2011/005147 KR2011005147W WO2012008747A3 WO 2012008747 A3 WO2012008747 A3 WO 2012008747A3 KR 2011005147 W KR2011005147 W KR 2011005147W WO 2012008747 A3 WO2012008747 A3 WO 2012008747A3
Authority
WO
WIPO (PCT)
Prior art keywords
skin
kit
diagnosing
conditions
diagnosis method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2011/005147
Other languages
French (fr)
Korean (ko)
Other versions
WO2012008747A2 (en
Inventor
김신형
오택진
김형준
손의동
강병영
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amorepacific Corp
Original Assignee
Amorepacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amorepacific Corp filed Critical Amorepacific Corp
Publication of WO2012008747A2 publication Critical patent/WO2012008747A2/en
Publication of WO2012008747A3 publication Critical patent/WO2012008747A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/02—Instruments for taking cell samples or for biopsy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

The present invention relates to a method for diagnosing skin conditions, comprising: a step of collecting skin or a skin secretion; and a step of measuring a biomarker of the skin or skin secretion collected in the previous step. The present invention also relates to a kit for diagnosing skin conditions, comprising: a unit for collecting skin or skin secretions; and a measuring unit which measures a biomarker of the skin or skin secretion. Skin conditions can be easily, conveniently, and quickly measured using the above-described method for diagnosing skin conditions and the kit for diagnosing skin conditions.
PCT/KR2011/005147 2010-07-13 2011-07-13 Skin diagnosis method and kit Ceased WO2012008747A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2010-0067483 2010-07-13
KR20100067483 2010-07-13

Publications (2)

Publication Number Publication Date
WO2012008747A2 WO2012008747A2 (en) 2012-01-19
WO2012008747A3 true WO2012008747A3 (en) 2012-08-23

Family

ID=45469922

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/005147 Ceased WO2012008747A2 (en) 2010-07-13 2011-07-13 Skin diagnosis method and kit

Country Status (2)

Country Link
KR (1) KR101409610B1 (en)
WO (1) WO2012008747A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102048877B1 (en) * 2012-11-30 2019-11-26 (주)아모레퍼시픽 Method and kit for determining damage of skin barrier
KR102350765B1 (en) * 2015-09-11 2022-01-12 삼성에스디에스 주식회사 System and method for managing data de-duplication dictionary
US20190328938A1 (en) 2016-12-28 2019-10-31 NEXMOS Co., Ltd Method for fabricating microneedle-based diagnostic skin patch coated with aptamer and patch
JP2023130972A (en) * 2022-03-08 2023-09-21 株式会社 資生堂 Yellow dullness suppression method, yellow dullness inhibitor screening method, and yellow dullness susceptibility evaluation method
KR102856481B1 (en) 2023-11-08 2025-09-09 경북대학교 산학협력단 Apparatus for microneedle automatic analysis using magnetic stirring elements and method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006141554A (en) * 2004-11-17 2006-06-08 Olympus Corp Cleansing sheet, information reader, skin condition-diagnosis device, information reading method, skin condition-diagnosis method, information-reading program, and skin condition-diagnosis program
KR20090021786A (en) * 2007-08-28 2009-03-04 (주)아모레퍼시픽 Skin Aging Diagnostic Kit and How to Diagnose Skin Aging
KR20100012892A (en) * 2010-01-21 2010-02-08 (주)아모레퍼시픽 Method and kit for diagnosis of skin aging

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07115995A (en) * 1993-10-27 1995-05-09 Shiseido Co Ltd Analysis of sebum component
JP4526839B2 (en) 2004-03-05 2010-08-18 株式会社資生堂 Method for evaluating the transparency and water retention of the stratum corneum using oxidized protein in the stratum corneum
CN101248192B (en) * 2005-08-23 2013-02-20 株式会社芳珂 Skin aging marker and technique for use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006141554A (en) * 2004-11-17 2006-06-08 Olympus Corp Cleansing sheet, information reader, skin condition-diagnosis device, information reading method, skin condition-diagnosis method, information-reading program, and skin condition-diagnosis program
KR20090021786A (en) * 2007-08-28 2009-03-04 (주)아모레퍼시픽 Skin Aging Diagnostic Kit and How to Diagnose Skin Aging
KR20100012892A (en) * 2010-01-21 2010-02-08 (주)아모레퍼시픽 Method and kit for diagnosis of skin aging

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JIN HO CHUNG ET AL.: "Modulation of Skin Collagen Metabolism in Aged and Photoaged Human Skin In Vivo", THE JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 117, no. 5, 2001, pages 1218 - 1224 *

Also Published As

Publication number Publication date
KR20120006945A (en) 2012-01-19
KR101409610B1 (en) 2014-06-20
WO2012008747A2 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
WO2012110878A3 (en) Method of diagnosing cancer and diagnosis kit using measurement of nk cell activity
WO2012012693A3 (en) Methods for detecting signatures of disease or conditions in bodily fluids
WO2012078623A3 (en) Biomarkers for monitoring treatment of neuropsychiatric diseases
IL219210A0 (en) Biomarkers and methods for measuring and monitoring inflammatory disease activity
BR112013001752A2 (en) method of detecting disease or condition using phagocytic cells
BR112013012460A2 (en) "Diagnostic Kit for Vaginal Health Benefit Biomarkers and Method for Detecting Vaginal Health Benefit Biomarkers"
WO2012009453A3 (en) Non-invasive monitoring of physiological conditions
WO2012021407A3 (en) Biomarkers for stroke
WO2013153461A3 (en) Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases
EP2659833A4 (en) Two-arm blood pressure measurement apparatus for automatically measuring two-arm blood pressures at the same time
WO2010103388A3 (en) Methods using axl as a biomarker of epithelial-to-mesnchymal transition
HK1206423A1 (en) Oligomeric a in the diagnosis, prognosis, and monitoring of alzheimer's disease
NZ716643A (en) Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event
EP2660310A4 (en) Comprehensive glaucoma determination method utilizing glaucoma diagnosis chip and deformed proteomics cluster analysis
WO2012012709A3 (en) Methods of detecting cardiovascular diseases or conditions
EP2623024A4 (en) Electronic blood pressure meter, method for estimating circumference length of measurement portion, and method for measuring blood pressure
WO2012008747A3 (en) Skin diagnosis method and kit
WO2012075023A3 (en) Neoantibodies for diagnosing tissue injury
MX359328B (en) Method for the diagnosis of niemann-pick disease.
WO2013009146A3 (en) Marker for diagnosing diabetic retinopathy
RU2010145662A (en) METHOD FOR PREDICTING THE RISK OF DEATH OF PATIENTS WITH CHRONIC HEART FAILURE
EP2572197A4 (en) METHOD AND COMPOSITION FOR DIAGNOSING AND MONITORING INFLAMMATORY DISEASES
WO2012145399A3 (en) Methods of diagnosing cancer in a patient
WO2011083461A3 (en) Method for diagnosing and monitoring schizophrenia and tauopathies
PL1990420T3 (en) Method for the detection of the in-vivo activity of neurotrypsin, use of the method and use of the C-terminal 22-kDa fragment of agrin as biomarker in diagnosis and monitoring of neurotrypsin-related disturbances

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11807032

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11807032

Country of ref document: EP

Kind code of ref document: A2